Herbas VPB

Print
EN | LT
LT - NAPI2B-TARGETED ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF
EN - NAPI2B-TARGETED ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 47/68 (2017.01)
A61K 47/6805 (2017.08)
A61P 35/00 (2006.01)
A61K 47/6811 (2017.08)
A61K 47/59 (2017.01)
A61K 47/6857 (2017.08)
A61K 47/6869 (2017.08)
A61K 47/6883 (2017.08)
A61K 47/6851 (2017.08)
A61P 35/00 (2018.01)
European patent
(11) Number of the document 3429693
(13) Kind of document T
(96) European patent application number 17713127.3
Date of filing the European patent application 2017-03-13
(97) Date of publication of the European application 2019-01-23
(45) Date of publication and mention of the grant of the patent 2023-08-23
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2017/022155
Date 2017-03-13
PCT application publication
(87) Number WO 2017/160754
Date 2017-09-21
Priority applications
(30) Number Date Country code
201662308567 P 2016-03-15 US
201662323068 P 2016-04-15 US
201662383324 P 2016-09-02 US
Inventors
(72)
BERGSTROM, Donald, A. , US
BODYAK, Natalya, D. , US
LOWINGER, Timothy, B. , US
PARK, Peter, U. , US
POLING, Laura, L. , US
YURKOVETSKIY, Aleksandr, V. , US
Grantee
(73) Mersana Therapeutics, Inc. , 840 Memorial Drive, Cambridge, MA 02139, US
Title
(54) NAPI2B-TARGETED ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF
  NAPI2B-TARGETED ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF